Logotype for Neogen Corporation

Neogen (NEOG) Q4 2024 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for Neogen Corporation

Q4 2024 earnings summary

2 Feb, 2026

Executive summary

  • Integration of 3M Food Safety products and services is nearly complete, with Petrifilm ramping up to full production and major milestones achieved, including relocation of sample handling lines and resolution of distribution inefficiencies.

  • Shipping and distribution challenges from integration have been resolved, and backlog levels are now reasonable, allowing a shift in focus to demand generation and operational efficiency for FY2025.

  • Food production volumes remained down year-over-year, but end market environment stabilized in Q4, with expectations for gradual improvement as food inflation eases.

  • Innovation and product launches, such as the USDA endorsement of the Molecular Detection System and the Petrifilm Automated Feeder, are expected to drive future growth.

  • End-market demand is stable but soft, with commercial focus shifting to demand generation.

Financial highlights

  • Q4 FY24 revenue was $237 million, down 2.1% year-over-year; core revenue grew 2% year-over-year.

  • Food Safety segment Q4 revenue was $167 million, down 1% year-over-year, with core growth of 4.3% led by Petrifilm and Pathogen Detection.

  • Animal Safety segment Q4 revenue was $70 million, with a 3.3% core revenue decline, mainly due to U.S. genomics.

  • Q4 gross margin was 47.9%, down from 50.9% a year ago; adjusted EBITDA was $53 million (22.4% margin), down from $63.1 million (26.1% margin) last year.

  • Adjusted net income was $22.4 million and adjusted EPS was $0.10, both down from prior year due to lower EBITDA.

Outlook and guidance

  • Fiscal 2025 revenue expected between $925 million and $955 million, with mid-single-digit core growth and margin expansion of ~100 basis points.

  • Adjusted EBITDA guidance for FY25 is $215–$235 million; capital expenditures projected at $85 million, with $55 million for integration.

  • Free cash flow expected to be strongly positive as CapEx and working capital investment decrease.

  • First half of FY25 anticipated to be lighter due to ongoing recovery from shipment constraints, with stronger growth in the second half.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more